1 / 28

Clinical Developments in Idiopathic Pulmonary Fibrosis: Expert Insights

Clinical Developments in Idiopathic Pulmonary Fibrosis: Expert Insights. Demographics of IPF in the US a-d. Major Goals of Treatment. Managing Shortness of Breath. Common Comorbidities in IPF. Additional Management Considerations. The State of IPF Management. Pirfenidone: The ASCEND Trial.

bell-lane
Download Presentation

Clinical Developments in Idiopathic Pulmonary Fibrosis: Expert Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Developments in Idiopathic Pulmonary Fibrosis: Expert Insights

  2. Demographics of IPF in the USa-d

  3. Major Goals of Treatment

  4. Managing Shortness of Breath

  5. Common Comorbidities in IPF

  6. Additional Management Considerations

  7. The State of IPF Management

  8. Pirfenidone: The ASCEND Trial

  9. Results

  10. Results (cont)

  11. Results (cont)

  12. Adverse Events

  13. Study Conclusions

  14. Nintedanib: INPULSIS-1 and INPULSIS-2

  15. Results

  16. Time to First Acute Exacerbation

  17. Adverse Events

  18. Study Conclusion

  19. Discussion of Potential Implications

  20. IPF Clinical Research Network: PANTHER Trial

  21. IPF Clinical Research Network: PANTHER Trial (cont)

  22. Results

  23. Conclusions

  24. Abbreviations

  25. References

  26. References (cont)

  27. References (cont)

  28. References (cont)

More Related